Other Clinical Trial - Mechanical Ventilation Parameters in HAP Patients

Status Completed

Clinical Trial Summary

Hospital-acquired pneumonia (HAP) in patients in intensive care often requires the mechanical ventilation (MV). Management and weaning from MV are given by specificity of this type of pulmonary inflammation. Enrolled in the retrospective, observational study were all patients older than 18 years staying at the ICU of University Hospital in Olomouc, between 1 January 2011 and 31 December 2016. The determination of the parameters of the MV, ICU length of stay, hospital length of stay and mortality in HAP group were compared with the control group of patients without HAP.

Clinical Trial Description

Hospital-acquired pneumonia (HAP) development influences the parameters of mechanical ventilation, intensive care unit (ICU) length of stay, hospital length of stay, need of tracheostomy, bronchoscopy, reconnection to MV and mortality. We respect HAP definition: acute inflammation of the respiratory bronchioles, alveolar structures and pulmonary interstitium. Clinically it is defined as the presence of newly developed or progressive infiltrates on chest radiographs plus at least two other signs of respiratory tract infection: temperature >38 °C, chest pain, purulent sputum, leukocytosis or leukopenia, signs of inflammation on auscultation, cough and/or respiratory insufficiency. HAP is defined as pneumonia that occurs 48 hours or more after admission, which was not incubating at the time of admission. A retrospective, observational study processing data on all consecutive intensive care patients older than 18 years of age between 1 January 2011 and 31 December 2015. The aim was to determine the incidence of potential risk factors and their impact on the development of HAP. The primary outcome was investigation of the relationship between mechanical ventilation parameters and the presence of early- and late-onset HAP. Enrolled in the study were patients staying at the ICU of the Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, between 1 January 2011 and 31 December 2016. The participants were all patients older than 18 years of age consecutively admitted to the ICU. ;

Study Design

Related Conditions & MeSH terms

Mechanical Ventilation Pressure High

Clinical Trial Details

NCT number	NCT03111303
Study type	Observational
Source	University Hospital Olomouc
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2011
Completion date	April 6, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02506270` - Effect of Airseal System Valve-less Trocar on the Ventilatory Parameters During Robotic-assisted Radical Cystectomy	N/A
Not yet recruiting	`NCT05341687` - Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
Recruiting	`NCT06168162` - Effect of Individualized PEEP on Postoperative Pulmonary Complication in Bariatrics	N/A
Completed	`NCT03721237` - Esophageal Balloon Calibration in Assisted Ventilation Mode	N/A
Not yet recruiting	`NCT06393179` - Epidemiology and Treatment Strategy of Open Respiratory Phenotype in Critically Ill Patients	N/A
Not yet recruiting	`NCT03854565` - Glycocalyx Biomarkers in ARDS for Clinical Prognosis and Pulmonary Fibrosis
Completed	`NCT04359251` - Different PEEP Settings of COVID-19 Induced ARDS	N/A
Not yet recruiting	`NCT06232915` - Accuracy of the Set Tidal Volume During Intraoperative Mechanical Ventilation
Completed	`NCT03589482` - Assessing Lung Inhomogeneity During Ventilation for Acute Hypoxemic Respiratory Failure	N/A
Recruiting	`NCT05902403` - Risk Factors for Prolonged Mechanical Ventilation in Elevated Mean Airway Pressure
Recruiting	`NCT05098717` - End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical Ventilation
Recruiting	`NCT05554536` - Evaluation of Regional Lung Mechanics in Obese Patients Undergoing Laparoscopic Surgery	N/A
Completed	`NCT02993887` - Resourcefulness Training and Decentering on Self-Management in Caregivers of Technology Dependent Children	N/A
Recruiting	`NCT03868982` - Lung Protection in ARDS Using Neurally Adjusted Ventilatory Assist	N/A
Recruiting	`NCT06256029` - Recruitment Maneuver in General Anesthesia for Laparoscopic Cholecystectomy	N/A
Recruiting	`NCT04924920` - Sigh35 and End-expiratory Occlusion Test (EEOT) for Assessing flUid Responsiveness in Critically Ill Patients Undergoing Pressure Support Ventilation	N/A
Completed	`NCT04723043` - The Effect of Ventilation Modes on Cerebral Oxymetry In Operation	N/A
Recruiting	`NCT06229886` - Effect of PEEP on TRJV in Mechanically Intubated Pediatric Patients	N/A
Recruiting	`NCT05150847` - Prone Positioning in COVID-19 Patients	N/A
Withdrawn	`NCT06093958` - Paradoxical Response to Chest Wall Loading in Mechanically Ventilated Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.